KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Adaptive Biotechnologies (ADPT) Non-Current Debt (2022 - 2025)

Historic Non-Current Debt for Adaptive Biotechnologies (ADPT) over the last 4 years, with Q3 2025 value amounting to $129.4 million.

  • Adaptive Biotechnologies' Non-Current Debt fell 248.0% to $129.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $129.4 million, marking a year-over-year decrease of 248.0%. This contributed to the annual value of $132.4 million for FY2024, which is 134.24% up from last year.
  • According to the latest figures from Q3 2025, Adaptive Biotechnologies' Non-Current Debt is $129.4 million, which was down 248.0% from $130.5 million recorded in Q2 2025.
  • Adaptive Biotechnologies' 5-year Non-Current Debt high stood at $132.7 million for Q3 2024, and its period low was $125.4 million during Q4 2022.
  • Moreover, its 4-year median value for Non-Current Debt was $131.1 million (2023), whereas its average is $130.3 million.
  • Per our database at Business Quant, Adaptive Biotechnologies' Non-Current Debt skyrocketed by 471.16% in 2024 and then plummeted by 248.0% in 2025.
  • Adaptive Biotechnologies' Non-Current Debt (Quarter) stood at $125.4 million in 2022, then rose by 4.23% to $130.7 million in 2023, then increased by 1.34% to $132.4 million in 2024, then fell by 2.27% to $129.4 million in 2025.
  • Its Non-Current Debt was $129.4 million in Q3 2025, compared to $130.5 million in Q2 2025 and $131.5 million in Q1 2025.